BACKGROUND
Immunohistochemical staining for cluster designation 5 (CD5) has been found to label a variety of non-lymphoid tumors.
METHODS
A variety of eccrine, apocrine, follicular, epithelial, and pagetoid lesions were selected and stained with an anti-CD5 monoclonal antibody (Novocastra Labs, Newcastle upon Tyne, UK, clone 4C7) by immunohistochemistry. The intensity of positive cytoplasmic ...